About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

Not Yet RecruitingNANCT07599189

Essential Oils for Urinary Symptoms in Multiple Sclerosis Patients

The goal of this clinical trial is to learn if essential oil aromatherapy works to improve urinary symptoms in adults with multiple sclerosis. It will also learn about the safety of essential oil use ...

Lead sponsor: University of Oran 1•2 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Zitouni-Nourine Saida Hanane

CONTACT

+213556623080 zitouni.saida@univ-oran1.dz

Sponsors

Lead Sponsor

University of Oran 1

Age

All ages

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Confirmed diagnosis of Multiple Sclerosis (any form)
•Documented lower urinary tract symptoms defined by an Overactive Bladder Symptom Score (OABSS) ≥ 3 at screening
•Age between 18 and 65 years
•Willing and able to provide written informed consent
•Capable of performing daily topical self-application of the study oil, or having a caregiver available to assist throughout the study period

Exclusion Criteria

•Active urinary tract infection confirmed by urine culture at screening
•Pre-existing urological condition unrelated to Multiple Sclerosis (e.g., bladder cancer, benign prostatic hyperplasia, or interstitial cystitis)
•Known allergy or hypersensitivity to essential oils, apricot kernel oil, lavender, or rosemary
•Active skin lesions, wounds, or dermatological conditions on the lower abdomen at the intended site of application
•Pregnancy, breastfeeding, or planning to become pregnant during the study period
•Significant cognitive impairment preventing understanding of study procedures or completion of questionnaires
•Current use of an indwelling urinary catheter or practice of intermittent self-catheterization

Related studies

Reducing Disparities in Urinary Control Symptoms for Minority Women

NCT06798311 · Urinary Incontinence (UI), Lower Urinary Tract Symptoms (LUTS), and more

URINARY INCONTINENCE AND PELVIC FLOOR MUSCLE ACTIVITY IN MULTIPLE SCLEROSIS

NCT07489794 · Multiple Sclerosis, Urinary Incontinence (UI)

RECRUITINGPhase 4

Ublituximab (Briumvi) for Early Forms of Relapsing Multiple Sclerosis

NCT07225361 · Multiple Sclerosis, Multiple Sclerosis (MS) - Relapsing-remitting

RECRUITINGPhase 1/2

Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy

NCT05359653 · Multiple Sclerosis (MS), Multiple Sclerosis, Relapsing-Remitting, and more

Wearable Focal Vibration Therapy on Upper Extremity Function of People With Multiple Sclerosis: A Pilot Study

NCT07376772 · Multiple Sclerosis (MS) - Relapsing-remitting, Upper Extremity Dysfunction

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: May 20, 2026Terms

Trial snapshot

StatusNOT_YET_RECRUITING

PhaseNA

Enrollment60

Start dateSep 2026

Last updatedMay 20, 2026

Condition

Multiple Sclerosis (MS)Neurogenic Bladder Disorder Urinary Incontinence (UI)Urinary Urgency Lower Urinary Tract Symptoms (LUTS)

Locations shown

Aboubakr abdelmadjid

Oran, Oran Province

Zitouni-Nourine Saida Hanane

Oran

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 20, 2026Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions